Cytotoxic lymphocytes share the presence of the activating receptor NK receptor group 2, member D (NKG2D) and the signaling-competent adaptor DNAX-activating protein 10 (DAP10), which together play an important role in antitumor immune surveillance. Ligand stimulation induces the internalization of NKG2D-DAP10 complexes and their delivery to lysosomes for degradation. In experiments with human NK cells and cell lines, we found that the ligand-induced endocytosis of NKG2D-DAP10 depended on the ubiquitylation of DAP10, which was also required for degradation of the internalized complexes. Moreover, through combined biochemical and microscopic analyses, we showed that ubiquitin-dependent receptor endocytosis was required for the activation of extracellular signal-regulated kinase (ERK) and NK cell functions, such as the secretion of cytotoxic granules and the inflammatory cytokine interferon-g. These results suggest that NKG2D-DAP10 endocytosis represents a means to decrease cell surface receptor abundance, as well as to control signaling outcome in cytotoxic lymphocytes.
INTRODUCTION
Cytotoxic lymphocytes are major players in the immune surveillance of cancer, because they selectively kill malignant cells as a result of their ability to recognize molecules induced by neoplastic transformation. Different subsets of human cytotoxic lymphocytes, including natural killer (NK) cells, CD8
+ ab T cells, and gd T cells, share the presence of the activating receptor NK receptor group 2, member D (NKG2D), which stimulates effector responses upon binding to its ligands (NKG2DLs): major histocompatibility complex (MHC) class I-related chain (MIC) A (MICA) and MICB, and UL16-binding proteins (ULBP1 to ULBP6) (1, 2) . The increase in the cell surface abundances of NKG2DLs is driven by genotoxic stress and other forms of stress that are associated with malignant transformation (3), thus rendering damaged cells susceptible to NKG2D-mediated cellular cytotoxicity (4) . The prominent role of this receptor in antitumor immune surveillance has been demonstrated by experiments with murine tumor models and NKG2D-deficient mice (5, 6) .
NKG2D is a C-type lectin receptor, which is composed of two disulfidelinked type II transmembrane glycoproteins bearing a short intracellular tail that is not endowed with signaling capacity. Thus, to propagate signals, human NKG2D needs to couple to the transmembrane adaptor DNAXactivating protein 10 (DAP10), which together form a hexameric structure composed of one NKG2D homodimer assembled with two DAP10 homodimers (7) . DAP10 contains in its cytoplasmic domain a tyrosine-based motif (YINM) that is involved in the recruitment of phosphatidylinositol 3-kinase (PI3K) and the complex between growth factor receptor-bound protein 2 (Grb2) and the guanine nucleotide exchange factor Vav1 (8) (9) (10) . This activating motif is similar to those found in costimulatory receptors, such as CD28, inducible costimulator (ICOS), and CD19 (11, 12) . Indeed, NKG2D provides a costimulatory rather than a stimulatory signal to activated T cells, acting in concert with other costimulatory molecules to modify the strength and duration of antigen-specific responses mediated by the T cell receptor (TCR). In NK cells, the functional outcome is the result of the integration of signals from a broad array of activating and inhibitory receptors (13, 14) , and NKG2D functions either as costimulatory or a stimulatory receptor depending on the activation status of the cell (15) . Activation of NKG2D on NK cells contributes to the innate immune response through the ability of the receptor to stimulate cytotoxicity against NKG2DL-bearing target cells, as well as to induce the production of various chemokines and cytokines, including interferon-g (IFN-g) (16) .
Numerous studies have reported that persistent exposure to NKG2DLs located on the surface of tumor cells, or released either in exosomes or as soluble molecules by proteolytic shedding, can decrease the cell surface abundance of receptors, which leads to the impairment of NKG2D-dependent antitumor functions of both NK cells and CD8 + T cells (17) (18) (19) (20) (21) . Receptor internalization and degradation upon ligand binding is a welldocumented means to dampen immune responses and excessive inflammation: by limiting the availability of activating receptors on the cell surface, cells become refractory to additional stimuli. Internalization and degradation of several immune receptors are dependent on the ubiquitin pathway (22) (23) (24) (25) (26) . In addition, endocytosis of some membrane receptors is now recognized as an important route that is instrumental for signal transduction (27, 28) . Several studies conducted on receptor tyrosine kinases (RTKs) and heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) have demonstrated that endocytosis is required to bring activated receptors in close proximity to key signaling components, including mitogen-activated protein kinases (MAPKs), located in endosomes, thereby enabling signal propagation (29) (30) (31) (32) (33) (34) .
In the case of immune receptors, endosomes could participate in both B cell and T cell signaling (35) (36) (37) (38) (39) ; however, little is currently known about the role that immune receptor endocytosis plays in controlling signaling and the functional responses of immune cells. With respect to the NKG2D-DAP10 complex, we previously demonstrated that NKG2D in human NK cells is subjected to internalization and subsequent lysosomal degradation upon ligand binding and that this process depends on ubiquitylation (26) ; however, whether DAP10 can undergo ubiquitylation and whether receptor endocytosis contributes to signaling are unclear. Here, we found that the engagement of NKG2D on NK cells resulted in the ubiquitylation of DAP10, which was required for the endocytosis and degradation of the NKG2D-DAP10 complex. Moreover, we demonstrated that signaling was initiated at the plasma membrane and then continued after the engaged NKG2D-DAP10 complexes were internalized and had trafficked to endosomes, which led to NK cell functional responses.
RESULTS

DAP10 undergoes ubiquitylation upon NKG2D engagement
We previously demonstrated the contribution of the ubiquitin pathway in the internalization and degradation of NKG2D upon stimulation with MICA-expressing target cells (26) . Here, we investigated whether the NKG2D-DAP10 complex underwent ubiquitylation. Because of the difficulty in detecting endogenous DAP10 with commercially available antibodies, we transfected the human NK cell line NKL with a plasmid encoding a green fluorescent protein (GFP)-tagged wild-type DAP10 to generate a stable cell line (DAP10WT-GFP NKL cells). These cells were mixed with target Ba/F3 cells expressing MICA (Ba/F3-MICA cells) at a 1:1 ratio, and after stimulation, DAP10 was immunoprecipitated from the NKL cell lysates with an anti-GFP monoclonal antibody (mAb) (Fig. 1A) . After 1 min of coincubation, in addition to a band corresponding to the DAP10-GFP fusion protein (~37 kD), Western blotting analysis revealed the presence of a specific activation-induced form of molecular mass~45 kD, which was compatible with the addition of a single ubiquitin moiety (8.5 kD) and is characteristic of monoubiquitylation. The anti-ubiquitin mAb FK2 detects both monoand polyubiquitylated proteins (40) , and in our hands, it recognized a band migrating at~45 kD, which suggested that DAP10 was monoubiquitylated (Fig. 1A) . Moreover, additional bands of higher molecular mass were also detected with the anti-ubiquitin antibody (Fig. 1A) . These bands could correspond to polyubiquitylated forms of DAP10 that were not revealed with the anti-GFP antibody because of their low abundance, or to ubiquitylated proteins that coimmunoprecipitated with DAP10. Samples subjected to immunoprecipitation with an isotype-matched control antibody did not show any reactivity at~45 kD or greater (Fig. 1A) . To confirm that DAP10 underwent ubiquitylation, we performed an in vitro ubiquitylation assay in which GFP-tagged DAP10 was immunoprecipitated from unstimulated DAP10WT-GFP NKL cells (Fig. 1B) . We observed a similar pattern of bands to those seen earlier (Fig. 1A) . Together, these results indicate that DAP10 is ubiquitylated.
The amino acid residue sequence of DAP10 contains only one lysine residue (Lys 84 ) (Fig. 1C) . To investigate the role of DAP10 ubiquitylation, we generated an NKL cell line expressing a DAP10-GFP fusion protein in which Lys 84 of DAP10 was mutated to an arginine (DAP10K84R). We first verified that this mutation did not alter the ability of DAP10(K84R) proteins to bind to NKG2D or to undergo phosphorylation in response to engagement of NKG2D ( fig. S1, A and B) . Furthermore, flow cytometric analysis revealed that comparable amounts of wild-type and mutant DAP10-GFP fusion proteins were present in both cell lines and that the DAP10 mutant did not alter the amount of cell surface NKG2D or that of other activating receptors not associated with DAP10, such as 2B4 ( fig. S1C ). We then compared the pattern of DAP10 ubiquitylation in cells expressing either wild-type DAP10 or DAP10(K84R) (Fig. 1D) . After 1 min of stimulation of the NKL cell lines with anti-NKG2D mAb, there was a substantial decrease in the intensity of the bands detected by the anti-ubiquitin antibody in samples from the DAP10(K84R)-GFP cells compared to those from the DAP10WT-GFP cells (Fig. 1D) . These results indicate that Lys 84 is the site of ubiquitylation of DAP10, and support the conclusion that the forms of higher molecular mass mainly represent polyubiquitylated DAP10 species.
The DAP10(K84R) mutant inhibits both the internalization and degradation of NKG2D-DAP10
To assess the effect of the K84R mutation on NKG2D-DAP10 internalization, we analyzed NKL transfectants using fluorescence microscopy upon stimulation with an anti-NKG2D mAb. In unstimulated cells, a uniform distribution of GFP was observed over the whole plasma membrane in cells expressing either DAP10WT-GFP or DAP10(K84R)-GFP ( Fig. 2A) . After 15 min of stimulation, DAP10WT-GFP protein was clearly detected inside the cells, whereas DAP10(K84R)-GFP appeared to be clustered but was still associated with the plasma membrane ( Fig. 2A ). Analysis at a later time (30 min) revealed that DAP10WT-GFP was internalized in about 80% of cells, whereas DAP10(K84R)-GFP was still localized in clusters on the plasma membrane in most cells (Fig. 2, A and  B) . Similar results were obtained by analyzing NKG2D internalization in cells expressing either DAP10WT-GFP or DAP10(K84R)-GFP 30 min after stimulation (Fig. 2C) , thus suggesting that mutation of DAP10 ubiquitylation site prevents the endocytosis of the engaged NKG2D-DAP10 complex.
We previously demonstrated that stimulated NKG2D is internalized and then subjected to lysosomal degradation (26) . Consistent with this finding, we found that engagement of NKG2D resulted in the degradation of both DAP10 and NKG2D in cells expressing DAP10WT-GFP, as revealed by decreased band intensities in samples from cells stimulated for 15 min (Fig. 3, A and B) . In contrast, receptor degradation was less substantial in cells expressing DAP10(K84R). The lack of a complete inhibition of NKG2D degradation in DAP10(K84R)-expressing cells might be explained by the presence of an additional internalization motif within the cytoplasmic tail of NKG2D but may also depend on the internalization and degradation of NKG2D that was associated with endogenous DAP10. Together, these results support a role for DAP10 ubiquitylation in driving NKG2D-DAP10 internalization and sorting to lysosomes for degradation.
DAP10 ubiquitylation is required for NKG2D-mediated ERK1/2 activation and NK cell functions
Several studies showed that the endocytosis of activated receptors is required not only to decrease their cell surface abundance but also to form specialized molecular platforms responsible for additional signal outputs (31-33); however, whether NKG2D internalization is necessary for signal The abundances of the DAP10 (A) and NKG2D (B) proteins, normalized to that of ZAP70, were determined by densitometric analysis and are expressed relative to the protein abundances of unstimulated cells (arbitrarily set to 1). Data are means ± SD of three independent experiments. *P < 0.05 by Student's t test.
propagation that leads to NK cell effector functions is unclear. To address this, we first compared the amounts of IFN-g secreted by DAP10WT-NKL and DAP10(K84R)-NKL cells upon NKG2D engagement. Full activation of the NK cell functional program results from the cooperation of more than one activating receptor (41); therefore, we stimulated NKG2D alone or in combination with stimulation of the activating receptor 2B4. Whereas stimulation with plate-bound anti-NKG2D or anti-2B4 mAb alone failed to stimulate either cell line to secrete IFN-g, the coengagement of both NKG2D and 2B4 led to IFN-g production by DAP10WT-NKL cells, but not DAP10(K84R)-NKL cells (Fig. 4A) .
We obtained similar results from experiments in which we analyzed the secretion of cytotoxic granules in response to the stimulation of NKL cell transfectants with FcR + P815 target cells that were coated with anti-NKG2D or anti-2B4 mAbs ( S2 ). The percentage of DAP10WT-GFP NKL cells that showed translocation of the cytolytic granule marker CD107a from the inner membrane of granules to the cell surface upon degranulation was substantially greater than that of similarly treated DAP10(K84R)-GFP NKL cells (Fig. 4B) . The observed differences were not the result of a general intrinsic functional defect of the DAP10(K84R)-expressing cells, because stimulation of these cells with interleukin-2 (IL-2) or phorbol 12-myristate 13-acetate (PMA) and ionomycin induced similar functional responses in DAP10WT-and DAP10(K84R)-expressing cells (Fig. 4B) .
To evaluate whether the impairment of NKG2D-mediated effector functions observed in the DAP10(K84R)-GFP NKL cells was a result of a defect in signal propagation, we assessed the phosphorylation events downstream of activation of NKG2D. After NKG2D engagement, Vav1 and the p85 regulatory subunit of PI3K are activated upon their recruitment to the phosphorylated YINM motif of DAP10 (9-11). We found that the extent of phosphorylation of both p85 and Vav1 was similar between DAP10WT-GFP NKL cells and DAP10(K84R)-GFP NKL cells (Fig. 4, C and D) , which suggested that early signaling events were not adversely affected by the mutation of DAP10. Among the signaling molecules involved in the activation of NK cell functions, the MAPKs extracellular signal-regulated kinases 1 and 2 (ERK1/2) play a key role in both (A) DAP10WT-GFP and DAP10(K84R)-GFP NKL cells were stimulated overnight with platebound anti-NKG2D and anti-2B4 mAbs alone or in combination, or with IL-2 (1000 U/ml). The amounts of IFN-g released into the cell culture media were measured by enzyme-linked immunosorbent assay (ELISA). Data are means ± SD of three independent experiments. *P < 0.05. (B) DAP10WT-GFP and DAP10(K84R)-GFP NKL cells were stimulated for 2 hours with P815 cells that were coated with anti-NKG2D or anti-2B4 mAbs alone or in combination, or were treated with PMA (50 ng/ml) and ionomycin (Iono) (500 ng/ml). Cell surface expression of CD107a was determined by flow cytometric analysis of GFP + cells, and data are expressed as the percentage of GFP + cells that were CD107a + . Data are means ± SD of three independent experiments. *P < 0.05. (C and D) Left: DAP10WT-GFP and DAP10(K84R)-GFP NKL cells were left unstimulated or were incubated with anti-NKG2D mAb and goat anti-mouse IgG for the indicated times. Cell lysates were then subjected to immunoprecipitation with anti-p85 mAb or with isotype-matched mAb (Ctrl). Immunoprecipitates (C) or total cell lysates (D) were then analyzed by Western blotting with the indicated antibodies. Blots are representative of three independent experiments. Right: The ratios of the abundances of the indicated pairs of total and phosphorylated proteins were determined by densitometric analysis. Data are means ± SD of three independent experiments. *P < 0.05 by Student's t test.
the exocytosis of cytolytic granules and the secretion of IFN-g (42) (43) (44) (45) . Therefore, we also compared the ERK1/2 activation status in the different NKL cell lines. We found that ERK1/2 phosphorylation in DAP10WT-GFP NKL cells was induced at 1 min after stimulation with anti-NKG2D antibody, peaked at 5 min, and then started to decrease after 10 min (Fig. 4D, bottom) ; however, there was a marked reduction in the phosphorylation of ERK1/2 in the DAP10(K84R)-GFP NKL cells, which suggests that DAP10 ubiquitylation was required for the full activation of ERK1/2 in response to NKG2D stimulation.
The ERK pathway targets specific components of the cytoskeleton (46); thus, we investigated whether impaired endocytosis of the NKG2D-DAP10 complex in DAP10(K84R)-GFP NKL cells was a consequence of the defect in ERK1/2 activation. We found that NKG2D-DAP10 complexes were internalized to a similar extent in DAP10WT-GFP NKL cells treated with vehicle or the MAPK kinase 1 (MEK1) inhibitor PD098059, which suggests that ERK activation was not involved in receptor endocytosis ( fig. S3 ). Together, these results suggest that DAP10 ubiquitylation is required not only for the lysosomal degradation of NKG2D and DAP10 but also for ERK1/2 activation and NK cell effector functions.
NKG2D endocytosis is required for the activation of ERK1/2
Because the DAP10(K84R) mutant was much less efficient than its wild-type counterpart in mediating NKG2D internalization and ERK1/2 phosphorylation, we postulated that the endocytosis of the NKG2D-DAP10 complex might be required for ERK activation. To determine whether the inhibition of NKG2D internalization affected signal propagation and NK cell functional response, we treated primary cultured human NK cells with dynasore, a selective inhibitor of the guanosine triphosphatase (GTPase) dynamin, which blocks both clathrin-dependent and clathrin-independent endocytosis (47) . By microscopic analysis, we observed that the inhibitor efficiently blocked receptor endocytosis induced by crosslinking with the anti-NKG2D mAb (Fig. 5A) . Moreover, we found that dynasore inhibited the release of CD107a + cytolytic granules induced by the engagement of NKG2D or 2B4 either alone or in combination (Fig. 5B) . Similar results were obtained upon stimulation of primary human NK cells with Ba/F3-MICA target cells ( fig. S4 ). Dynasore-treated primary NK cells did not show general defects in granule exocytosis because they responded to PMA and ionomycin, a nonspecific stimulatory signal (Fig. 5B) .
Treatment of primary NK cells with dynasore had no effect on the extent of phosphorylation of either Vav1 or Akt in response to stimulation with an anti-NKG2D antibody (Fig. 5C) ; however, primary NK cells treated with the inhibitor showed a defect in ERK1/2 phosphorylation (Fig. 5C) , which was comparable to the defect observed in DAP10(R84R)-GFP NKL cells (Fig. 4D) . We then used a small interfering RNA (siRNA)-based approach combined with confocal microscopy and biochemical analysis. Transfection of parental NKL cells with dynamin 2-specific siRNA led to about a 60% reduction in the abundance of dynamin 2 compared to that in cells transfected with nontargeting control siRNA (Fig. 6A) . Consistent with the results obtained from the experiments with dynasore, knockdown of dynamin 2 reduced the extent of NKG2D endocytosis (Fig. 6B ) and ERK1/2 phosphorylation (Fig. 6C) upon receptor stimulation. Together, our results indicate that ERK1/2 activation and NK cell effector functions depend on the endocytosis of NKG2D, which suggests that the distribution of activated receptor complexes in endosomal compartments enables signal propagation.
Phosphorylated ERK1/2 and internalized NKG2D-DAP10 complexes colocalize with early endosomes upon receptor engagement
Several studies have demonstrated that the activation of the ERK signaling pathway can take place in endosomes (29) (30) (31) (32) (33) (34) . To study whether phosphorylated ERK1/2 (pERK) and internalized NKG2D-DAP10 complexes accumulated in early endosomal compartments, we performed double staining of pERK and the endosomal marker EEA1 (early endosome antigen 1) in DAP10WT-GFP NKL cells upon stimulation with anti-NKG2D mAb, and we analyzed the colocalization of DAP10-GFP with EEA1-positive endosomes. The signal corresponding to pERK increased upon NKG2D stimulation; during the first 5 min of stimulation, we observed only a slight increase in pERK immunostaining, which reached a maximum at 10 min and declined at 15 min ( fig. S5 ). Thus, colocalization between active ERK1/2 and EEA1-positive endosomes was evaluated at these latter time points. Colocalization was transient, reaching a maximum at 10 min (Fig. 7,  A and B, left) , and decreasing at 15 min (Fig. 7B, left) . In addition, we found that the DAP10-GFP fusion proteins also colocalized with EEA1-containing compartments with overlapping kinetics (Fig. 7, A and  B, left) . Furthermore, the colocalization indexes for DAP10-GFP/EEA1 and pERK/EEA1 that were calculated for each cell at 10 min of stimulation showed a positive correlation (R = 0.75; P < 0.0001) (Fig. 7B, right) . These results indicate that internalized NKG2D-DAP10 complexes and pERK1/2 transiently localize in early endosomes, which suggests that receptor internalization may be required for the recruitment of ERK1/2 into this compartment and for its activation.
DISCUSSION
Much evidence suggests that upon ligand binding, NKG2D-DAP10 complexes are internalized from the surface of NK cells and CD8 + T cells and are subjected to subsequent degradation in lysosomes (17, 26, 48) . However, to date, little is known about the molecular mechanisms that control NKG2D-DAP10 endocytosis or about its possible connection with downstream signaling. Here, we found that upon NKG2D engagement on human NK cells, DAP10 was subjected to ubiquitylation ( Fig. 1) and that this modification was required for endocytosis of the NKG2D-DAP10 complex (Fig. 2) . The involvement of the cytoplasmic domain of DAP10 in its internalization was previously reported in several studies, and tyrosine phosphorylation in the YINM motif is indispensable for endocytosis NKL cells were transfected with dynamin 2-specific siRNA or with control siRNA. Left: Forty-eight hours later, whole-cell lysates were analyzed by Western blotting with the indicated antibodies. Middle: The amounts of dynamin protein, normalized to that of ZAP70, were determined by densitometric analysis and are relative to that in unstimulated cells (which was arbitrarily set to 1). Data are means ± SD of three independent experiments. Right: The amounts of dynamin2 mRNA, normalized to that of GAPDH mRNA, were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis and are expressed as the fold change relative to that in cells transfected with control siRNA. Data are means ± SD of three independent experiments. (B) NKL cells transfected with the indicated siRNAs were stimulated for 30 min at 37°C and analyzed as described for Fig. 2C . Scale bar, 5 mm. (C) NKL cells transfected with the indicated siRNAs were left unstimulated or were incubated at 37°C with anti-NKG2D and goat anti-mouse IgG for the indicated times. Left: Wholecell lysates were analyzed by Western blotting with the indicated antibodies. The black vertical lines indicate noncontiguous blots. Right: The ratios of the abundances of the indicated pairs of total and phosphorylated proteins were determined by densitometric analysis. Data are means ± SD of three independent experiments. **P < 0.01, *P < 0.05 by Student's t test. (48, 49) . Here, we demonstrated that in addition to phosphorylation of DAP10, its ubiquitylation was also required for the endocytosis of engaged receptor complexes. We further found that DAP10 ubiquitylation was essential for degradation of the NKG2D-DAP10 complex (Fig. 3) , which is consistent with a study that demonstrated that a chimeric protein in which ubiquitin was fused to the C terminus of mouse DAP10 targeted DAP10-ubiquitin and NKG2D for constitutive internalization and degradation (50) .
The major finding of our study is that the ubiquitin-dependent endocytosis of the engaged NKG2D-DAP10 complex was required for efficient activation of NK cell effector functions, in terms of both cytolytic granule exocytosis and IFN-g release (Fig. 4, A and B) . Experiments with primary NK cells in which endocytosis was inhibited showed that cytolytic granule secretion induced by 2B4 engagement alone was substantially impaired (Fig. 5B) . Together, these results suggest that signaling from endosomal compartments is required to enable full NK cell activation. With respect to signaling, we found that receptor-proximal phosphorylation events did not require receptor endocytosis (Figs. 4, C and D, 5C, and 6C) . However, we found that the phosphorylation of ERK1/2 was impaired in NK cells in which endocytosis was inhibited (Figs. 4D, 5C , and 6C). Moreover, pERK transiently associated with endosomal compartments in which internalized DAP10-GFP fusion proteins were also present (Fig. 7) .
Together, our findings led us to propose a model ( fig. S6 ) in which the ubiquitin-dependent internalization of NKG2D-DAP10 and its trafficking along endosomes are required for the activation of ERK1/2 in endosomal compartments before the receptors reach lysosomes and undergo degradation. We propose that pERK could then detach from endosomes or translocate to the nucleus to reach its targets, thus enabling signal propagation and the functional response. With regard to other immune receptors, there is little evidence in support of a role of endosomal signaling. In the case of the B cell receptor (BCR), intracellular trafficking of the receptor is important to control the correct extent of activation of the MAPK and Akt signaling pathways and their downstream effects (35) , and components that activate c-Jun N-terminal kinase (JNK) are recruited in proximity to active BCR in endosomes (36) . Endosomes may also participate in T cell signaling; upon TCR stimulation, there is an accumulation of phosphorylated CD3z in endosomes (37) , and the phosphorylated adaptor protein LAT (linker of activated T cells) can be found in intracellular vesicles (38) . Moreover, TCR internalization ensures the appropriate signaling strength that is required to promote the proliferation of mouse T cells in vivo (39) . Different scenarios are exemplified by Toll-like receptor 4 (TLR4), which activates diverse signaling pathways based on its location (at the cell surface versus in endosomes) (51) , and by killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4), an activating receptor found on NK cells and some T cell subsets, which accumulates in early endosomes to initiate a proinflammatory cascade (52, 53) . Endosomal signaling has been extensively investigated in the cases of the RTK and GPCR families, in which it controls processes such as proliferation, differentiation, and inflammation (28) . The rate of internalization of such receptors is substantially higher than the rate of their lysosomal targeting and degradation. As a consequence, there is a prolonged residence of these signaling receptors in endosomes after ligand-induced endocytosis, and signaling is sustained (54) (55) (56) (57) . With respect to NKG2D-DAP10, we found that receptor internalization was rapidly followed by lysosomal degradation, suggesting that the contribution of endosomal signaling would serve to guarantee signal propagation, rather than to sustain it. Indeed, in cytotoxic lymphocytes, the exocytosis of cytolytic granules is a rapid process, which is highly controlled and directed to the appropriate target.
In the context of an NK cell, for which the functional response is the result of a delicate balance of signals from activating and inhibitory receptors (14) , compartmentalization of transducing components between the cell surface and endosomal membranes could serve to better control the outcome of receptor engagement. Moreover, endosomes may represent platforms for the integration of synergistic signals triggered by different engaged receptors, thus adding an extensive and complex level of functional regulation. In conclusion, we demonstrated that the ubiquitindependent endocytosis of an immune receptor served to regulate effector functions, and we provided evidence that a cooperative interaction between NKG2D signaling and endocytosis is required to enable NKG2D-mediated NK cell functions.
MATERIALS AND METHODS
Cell culture
The human NK cell line NKL was cultured in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS) and recombinant human IL-2 (200 U/ml; R&D Systems). All biochemical studies and IFN-g release assays were performed with NKL cells after 24 hours of IL-2 deprivation. Human NK cell cultures were obtained by coculturing peripheral blood mononuclear cells with irradiated RPMI 8866 cells for 10 days at 37°C in a humidified 5% CO 2 atmosphere. On day 10, the cell population was routinely 80 to 95% CD56 + , CD16 + , and CD3
− as assessed by immunofluorescence and flow cytometric analysis. Experiments were then performed on NK cell populations that were >90% pure. The Ba/F3-MICA and Ba/ F3-CD48 cell lines were provided by L. L. Lanier (University of San Francisco) and were maintained in RPMI medium supplemented with 10% FCS. The P815 murine mastocytoma FcRg + cell line was grown in RPMI medium supplemented with 10% FCS.
NK cell stimulation
NKL cell stimulation (Fig. 1A) was performed with fixed Ba/F3-MICA target cells. Briefly, target cells were treated with 1% PFA for 30 min at room temperature, washed extensively in cold phosphate-buffered saline (PBS), suspended in RPMI medium, and then added to the NKL cells. The stimulation was stopped by washing with cold PBS, and lysis buffer was added to both the effector and fixed target cells, whose lysis was prevented by the pretreatment with 1% PFA, as previously reported (45) . For stimulation with anti-NKG2D antibody, NKL cells or primary cultured NK cells were incubated with anti-NKG2D mAb (clone 149810, R&D Systems) for 30 min on ice. Goat anti-mouse antibody (Jackson ImmunoResearch) was added and incubated at 37°C for the times indicated in the figure legends. To visualize NKG2D by microscopic analysis, receptor engagement was achieved with an Alexa Fluor 350-conjugated goat anti-mouse IgG1 (Invitrogen). Pervanadate was freshly prepared by mixing 50 mM vanadate and 50 mM H 2 O 2 in PBS to give a 25 mM solution of pervanadate, which was then diluted in cell culture medium to give a final concentration of 1 mM. To inhibit endocytosis, primary cultured NK cells were pretreated at 37°C for 30 min with 100 mM dynasore (Sigma-Aldrich). To inhibit ERK1/2 activation, NKL cells were incubated at 37°C for 1 hour with the MEK1 inhibitor PD98059 (Millipore). Stimulation was conducted in the presence of the respective inhibitors. Cell viability was >90% before stimulation.
Plasmids, transfections, and siRNAs
The complementary DNA (cDNA) encoding full-length human Dap10 was subcloned from the total cDNA of the NKL cell line by RT-PCR assay with gene-specific primers (forward: 5′-gagagatcttccaccatgatccatctgg-3′; reverse: 5′-gtggatccctgcctggcatgttgatgt-3′), and the fragment was inserted into the pEGFP-N1 vector (Clontech Laboratories) at the Bgl II and Bam H1 sites to generate a construct encoding GFP fused to the C terminus of DAP10. The DAP10(K84R)-GFP mutant was prepared by PCR (QuikChange Site-Directed Mutagenesis Kit, Stratagene) using the pEGFP-N1-DAP10-GFP plasmid as template and the following primers: forward, 5′-cgcccaagatggcagagtctacatcaacatgcc-3′; reverse, 5′-ggcatgttgatgtagactctgccatcttgggcg-3′. The integrity of the plasmid constructs was verified by DNA sequence analysis. The plasmids were digested with Ase I, and NKL cells were transfected with 2.5 mg of linearized plasmids with the Amaxa 4D-Nucleofector System, SF solution, program EO-100 (Lonza Group Ltd.). Transfected cells were grown under selection with G418 (1 mg/ml), and the bulk stable cells were sorted on the basis of GFP abundance with a FACSAria sorter (BD Biosciences) equipped with a 488-nm laser and FACSDiva software (version 6.1.3, BD Biosciences). Briefly, cells first gated by forward and side scatter (FSC-A and SSC-A) were then detected in the green fluorescence channel for comparable GFP abundance. Dynamin 2-specific siRNA (5′-AAGGACCAGGCAGAAAACGAG-3′) and a control nontargeting siRNA (5′-UAAGGCUAUGAAGAGAUACUU-3′) were purchased from Eurofins MWG Operon. Specific protein knockdown was achieved by transfecting NKL cells with siRNA duplexes by electroporation with an Amaxa 4D-Nucleofector System (Lonza). Briefly, 2 × 10 6 cells were resuspended in 100 ml of Amaxa SF solution, mixed with 600 pmol of siRNA, and transfected with program CM-137. Forty-eight hours after transfection, the knockdown efficiency was evaluated by Western blotting and qRT-PCR analyses.
RNA isolation and qRT-PCR analysis
Total RNA isolation and reverse transcription were performed as previously described (58) . Real-time PCR analysis was performed with TaqMan assays and the ABI Prism 7900 Sequence Detection system (Applied Biosystems). The cDNAs were amplified in triplicate with primers specific for dynamin 2 (Hs00974698_m1) conjugated with the fluorochrome FAM (Applied Biosystems). The abundance of dynamin2 mRNA was measured as previously described (58) , and all samples were normalized to the abundance of GAPDH mRNA.
Immunoprecipitation and Western blotting analysis
Cells were lysed in a buffer (pH 7.5) containing 1% Triton X-100, 50 mM tris-HCl (pH 7.5), 150 mM NaCl, 2.5 mM EGTA (pH 8), 2.5 mM EDTA (pH 8), 1.5 mM MgCl 2 , 1 mM phenylmethylsulfonyl fluoride, 1 mM Na 3 VO 4 , 5 mM NaF (pH 8), 5 mM N-ethylmaleimide, aprotinin (10 mg/ml), and leupeptin (5 mg/ml). Immunoprecipitations were performed by binding the appropriate antibodies to protein A-Sepharose beads (Amersham Pharmacia) or protein G-Sepharose beads (Sigma-Aldrich), and then incubating them with equal amounts of protein from the cell lysates of each sample. The immunoprecipitates were washed five times with lysis buffer, and bound proteins were eluted with Laemmli buffer containing 5% 2-mercaptoethanol. Immunoprecipitates or total cell lysates were resolved by SDS-PAGE and transferred to nitrocellulose filters. After undergoing blocking of nonspecific reactivity, filters were incubated with specific primary and secondary antibodies diluted in TBS-T [20 mM tris-HCl (pH 7.8), 150 mM NaCl, 0.05% Tween 20] . After extensive washing, the immunoreactive bands were detected with an enhanced chemiluminescence detection kit (Amersham Pharmacia). The following antibodies were used for immunoprecipitation and Western blotting: anti-GFP (Invitrogen); anti-NKG2D (clone 3.1.1.1), anti-ZAP70, anti-phosphotyrosine, anti-Vav1, and anti-p85 (all from Millipore); anti-Akt, anti-pAkt (S473), anti-ERK1/2, and anti-pERK1/2(T202/Y204) (all from Cell Signaling Technology); antiubiquitin (clone FK2, Enzo Life Sciences); anti-dynamin 2 (5E4C2F3, Santa Cruz Biotechnology); and anti-pVav (Y160) (Life Technologies). Densitometric analysis was performed with ImageJ software.
In vitro ubiquitylation assay DAP10-GFP was immunoprecipitated from unstimulated DAP10WT-GFP NKL cells and used as source of substrate for in vitro ubiquitylation assays. The immunocomplexes were washed five times with lysis buffer and once with 1× ubiquitylation buffer [50 mM tris (pH 7.5), 0.5 mM MgCl 2 , 0.1 mM adenosine triphosphate, 0.1 mM dithiothreitol, 1 mM creatine phosphate] and incubated in 40 ml of the same buffer supplemented with 70% (v/v) RRLs, creatine phosphokinase (10 U), and 10 mg of ubiquitin for 2 hours at 30°C (23) . After in vitro ubiquitylation, all samples were washed three times with lysis buffer, eluted with SDS sample buffer, resolved by SDS-PAGE, and transferred electrophoretically to nitrocellulose filters.
Immunofluorescence and microscopic analysis NKL cells or primary cultured NK cells were stimulated with anti-NKG2D mAb as described earlier. After stimulation, the cells were gently resuspended, plated on poly-L-lysine-coated multichamber glass plates, and fixed with 4% PFA. After extensive washing, the coverslips were mounted with SlowFade Gold reagent (Life Technologies) and acquired at room temperature with an ApoTome Observer Z.1 microscope with a 63×/1.4 NA (numerical aperture) Plan-Neofluar oil immersion objective (Carl Zeiss), as previously described (59, 60) . When colocalization analysis was required, cells were permeabilized with 0.1% Triton X-100 for 5 min to stain intracellular antigens, and were incubated with the following antibodies diluted in blocking buffer (0.01% Triton X-100, 1% FCS): antipERK1/2 (Cell Signaling Technologies) followed by an Alexa Fluor 594-conjugated goat anti-rabbit antibody (Invitrogen); anti-EEA1 (Santa Cruz Biotechnology), which was conjugated with Pacific Blue with an Antibody Labeling Kit (Life Technologies). High-resolution images (640 × 640 pixel, 10 ms/pixel) were acquired with a FV1200 MPE laser-scanning confocal microscope (Olympus) with a 60×/1.35 NA UPlanSAPO oil immersion objective. Sequential acquisition was used to avoid crosstalk between different fluorophores. Quantification of colocalization was performed with FluoView 4.2 software, considering colocalization indexes between two channels on single cells (ROI) after background correction. Images were processed with ImageJ software.
NK cell functional assays
Degranulation of NK cells was determined by detection of the cell surface expression of CD107a, as previously described (41), with some modifications. Briefly, P815 cells (2 × 10 5 ) were incubated for 15 min at room temperature with 2 mg of the following mAbs: anti-NKG2D (R&D Systems), anti-2B4 (Beckman Coulter), or both. NK cells (1 × 10 5 ) were then mixed with P815, Ba/F3-MICA, or Ba/F3-CD48 cells, and the cells were centrifuged for 1 min at 100g and incubated for 2 hours at 37°C. Thereafter, cells were washed with PBS/5 mM EDTA, fixed with 2% PFA, and stained with allophycocyanin (APC)-conjugated anti-CD107a mAb or with isotope control (BD Biosciences) and, when primary NK cells were used, with peridinin chlorophyll protein (PerCP)-conjugated anti-CD3 antibody and phycoerythrin (PE)-conjugated anti-CD56 mAbs (BD Biosciences). Flow cytometric analysis was performed with a BD FACSCanto II flow cytometer equipped with 488-and 633-nm lasers and with DIVA software (BD Biosciences). NKL cells were gated on the basis of GFP abundance (GFP + cells), whereas primary NK cells were gated as CD3 − and CD56 + cells. To measure IFN-g release by ELISA, NKL cells were stimulated with IL-2 (1000 U/ml) or with plate-bound mAbs in flat-bottomed 96-well plates in which the wells were coated with goat anti-mouse immunoglobulin G (IgG) (2 mg per well in PBS) overnight at 4°C and then for 1 hour at 37°C with mAbs (1 mg per well in PBS). After washing, NKL cells (2 × 10 5 cells per well in RPMI medium supplemented with 10% FCS) were added onto the plates and were left overnight at 37°C before cell culture medium was collected. IFN-g concentrations were measured with the human IFN-g ELISA kit (Thermo Scientific).
Statistical analysis
For normally distributed data, statistical significance of differences between two groups was determined by performing two-tailed, paired Student's t tests. Data shown in graphs are means ± SD of at least three independent experiments. Linear regression analyses were performed to determine correlations between normally distributed data variables (colocalization indexes). Correlations are presented by expressing the Pearson's correlation coefficient R together with the P value for related statistical significance.
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